SARS-CoV-2-IN-110
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
SARS-CoV-2-IN-110 (compound Bb1) is an inhibitor of SARS-CoV-2, demonstrating antiviral efficacy with an EC50 of 1.10 μM, and significantly reduced toxicity compared to Lapatinib. The compound exhibits a CC50 of greater than 100 μM against SARS-CoV-2, with a selectivity index (SI) exceeding 91.
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3911602 1.0 µg DNA
Tnni3 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 46914116 3x 1.0 µg
Tmem150b sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
CST 12029T 20 µL
TRXR2/TXNRD2 (3F2-E12-F10) Mouse Monoclonal Antibody
Sign In for Pricing
View Details 038242-ML405 100 µL
MBD4, ID (Methyl-CpG-binding Domain 4) (MaxLight 405) discontinued
Sign In for Pricing
View Details